Comparable stake leader
Legorreta G. Pablo
SEC ownership of Royalty Pharma plc
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001802768.
Disclosed value leader
Legorreta G. Pablo
Comparable rows
50/50
Latest evidence
12 Jun 2026
- Public ticker
- RPRX on Nasdaq
- Parsed ownership sources
-
13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Legorreta G. Pablo
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Legorreta G. Pablo
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
12 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001802768
- Issuer location
- New York, NY
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Royalty Pharma plc (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Legorreta G. Pablo
Disclosed value leader
Legorreta G. Pablo
Comparable rows
50/50
Latest evidence
12 Jun 2026
13D/G
3/4/5
13F
Lead comparable stake: 20%
13D/G row: Legorreta G. Pablo
Showing 1-8 of 50 holder rows.
Quick read
Legorreta G. Pablo leads the comparable SEC ownership view at 20%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Legorreta G. Pablo's linked filing trail.
Comparable ownership
Top 5
Legorreta G. Pablo
20%
MORGAN STANLEY
9.2%
Capital International Investors
8.8%
FMR LLC
6.5%
BlackRock, Inc.
5.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Legorreta G. Pablo |
13D/G
3/4/5
CEO, Chairman of the Board, Director
|
20%
|
$3,372,819,557
103,112,796 shares
|
$0 | 16 May 2025 |
| MORGAN STANLEY |
13F
13D/G
Company
|
9.2%
from 13D/G
|
$2,090,131,406
43,571,633 shares
|
— | 31 Mar 2026 |
| Capital International Investors |
13F
13D/G
Company
|
8.8%
from 13D/G
|
$1,679,225,156
35,005,736 shares
|
— | 31 Mar 2026 |
| FMR LLC |
13F
13D/G
Company
|
6.5%
from 13D/G
|
$1,206,553,066
25,152,242 shares
|
— | 31 Mar 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
5.7%
from 13D/G
|
$1,242,794,508
25,907,745 shares
|
— | 31 Mar 2026 |
| Severgnini Achille G. |
13D/G
|
4.8%
|
$1,164,070,183
21,366,927 shares
|
-$155,603,324 | 12 Jun 2026 |
| GENERAL ATLANTIC, L.P. |
13D/G
|
3.2%
|
$510,500,301
14,243,870 shares
|
$0 | 30 Jun 2025 |
| VANGUARD GROUP INC |
13D/G
The Vanguard Group
|
2.5%
|
$385,841,061
10,936,538 shares
|
$0 | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$73,213,042.
Buys
$0
Insiders: 0
Sells
$73,213,042
Insiders: 5
Net
-$73,213,042
Shares: -1,720,987
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 1,720,987
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 323,492 | $0 | $17,160,172 | -$17,160,172 |
| 3-6 | 0 | 587,078 | $0 | $24,562,475 | -$24,562,475 |
| 6-9 | 0 | 776,917 | $0 | $30,276,646 | -$30,276,646 |
| 9-12 | 0 | 33,500 | $0 | $1,213,749 | -$1,213,749 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 25 reporting-owner rows connected to Royalty Pharma plc. Open a relationship link for the CIK-to-CIK filing trail.
Rows
25
Largest Forms 3/4/5 holder
Legorreta G. Pablo
Net 12M change
-$73,213,042
Latest report
24 Jun 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Legorreta G. Pablo | CEO, Chairman of the Board, Director | $2,828,861,031 | Mixed | 06 May 2026 | ||
| GG 1978 SICAF SIF S.A. | 10%+ Owner | $608,282,853 | Mixed | 14 Sep 2022 | ||
| GG 1978 SICAF SIF S.A. - GG Strategic | 10%+ Owner | $590,239,561 | Mixed | 20 Sep 2022 | ||
| George W. Lloyd | EVP, Investments & CLO | $300,616,992 | -$13,807,997 | -4.4% | Mixed | 17 Dec 2025 |
| Terrance P. Coyne | Evp & Cfo | $233,519,976 | -$38,310,356 | -14% | Mixed | 26 May 2026 |
| Mario Germano Giuliani | Director, 10%+ Owner | $96,010,741 | Mixed | 23 Jun 2023 | ||
| William E. Ford | Director | $71,241,786 | Mixed | 30 Jun 2021 | ||
| Avara Management Ltd | 10%+ Owner | $68,463,141 | Mixed | 29 Dec 2023 | ||
| Christopher Hite | EVP & Chairman, Partnering | $33,830,936 | -$8,159,277 | -19% | Mixed | 23 Jun 2026 |
| James F. Reddoch | EVP & Chief Scientific Officer | $23,300,586 | Mixed | 28 Sep 2022 | ||
| Rory B. Riggs | Director | $11,577,870 | Mixed | 20 Feb 2024 | ||
| Gregory Norden | Director | $9,418,813 | -$1,375,134 | -13% | Median | 05 Jun 2026 |
| Errol B. Desouza | Director | $4,828,170 | Mixed | 13 May 2025 | ||
| Ted W. Love | Director | $4,198,687 | Mixed | 05 Jun 2026 | ||
| Henry A. Fernandez | Director | $4,190,575 | Mixed | 30 Jun 2025 | ||
| Catherine M. Engelbert | Director | $3,985,987 | Mixed | 05 Jun 2026 | ||
| Bonnie L. Bassler | Director | $3,765,261 | Median | 05 Jun 2026 | ||
| David C. Hodgson | Director | $2,594,058 | Mixed | 05 Jun 2026 | ||
| Marshall Urist | EVP, Research & Investments | $1,414,510 | -$11,560,278 | -89% | Mixed | 24 Jun 2026 |
| Vlad Coric | Director | $736,003 | Median | 05 Jun 2026 |
Recent insider transactions for Royalty Pharma plc
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -50% | $502,067 | $55.18 | -9,098 | 9,099 | 24 Jun 2026 | Direct |
| Christopher Hite | RPRX | Class A Ordinary Shares | Sale | -21.1% | $8,159,277 | $54.40 | -150,000 | 559,399 | 23 Jun 2026 | By SCH Investment Partners LLC |
| Elizabeth H. Weatherman | RPRX | Class A Ordinary Shares | Award | 53.1% | 4,545 | 13,103 | 05 Jun 2026 | Direct | ||
| Gregory Norden | RPRX | Class A Ordinary Shares | Award | 2.37% | 4,545 | 196,348 | 05 Jun 2026 | Direct | ||
| Ted W. Love | RPRX | Class A Ordinary Shares | Award | 8.44% | 4,545 | 58,393 | 05 Jun 2026 | Direct | ||
| David C. Hodgson | RPRX | Class A Ordinary Shares | Award | 13.6% | 4,545 | 37,873 | 05 Jun 2026 | Direct | ||
| Carole Ho | RPRX | Class A Ordinary Shares | Award | 4,545 | 4,545 | 05 Jun 2026 | Direct | |||
| Catherine M. Engelbert | RPRX | Class A Ordinary Shares | Award | 8.89% | 4,545 | 55,673 | 05 Jun 2026 | Direct | ||
| Vlad Coric | RPRX | Class A Ordinary Shares | Award | 42.1% | 4,545 | 15,343 | 05 Jun 2026 | Direct | ||
| Bonnie L. Bassler | RPRX | Class A Ordinary Shares | Award | 6.15% | 4,545 | 78,492 | 05 Jun 2026 | Direct | ||
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -100% | $3,476,116 | $53.98 | -64,399 | 0 | 26 May 2026 | TPC RP EPA1 LLC |
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -42.9% | $721,838 | $52.75 | -13,684 | 18,197 | 20 May 2026 | Direct |
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -30% | $726,137 | $53.06 | -13,684 | 31,881 | 14 May 2026 | Direct |
| Gregory Norden | RPRX | Class A Ordinary Shares | Sale | -1.56% | $161,385 | $53.00 | -3,045 | 191,803 | 14 May 2026 | Direct |
| Pablo G. Legorreta | RPRX | Class A Ordinary Shares | Award | 13.1% | 143,821 | 1,242,604 | 06 May 2026 | Direct | ||
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Award | 60.4% | 24,263 | 64,399 | 06 May 2026 | TPC RP EPA1 LLC | ||
| Christopher Hite | RPRX | Class A Ordinary Shares | Award | 3.54% | 24,263 | 709,399 | 06 May 2026 | By SCH Investment Partners LLC | ||
| Marshall Urist | RPRX | Class A Ordinary Shares | Award | 66.5% | 18,197 | 45,565 | 06 May 2026 | Direct | ||
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -4.46% | $93,334 | $49.78 | -1,875 | 40,136 | 28 Apr 2026 | TPC RP EPA1 LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -100% | $1,638,506 | $49.78 | -32,916 | 0 | 28 Apr 2026 | By TPC RP 2021, LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -50% | $1,590,890 | $48.33 | -32,916 | 32,916 | 01 Apr 2026 | By TPC RP 2021, LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -4.27% | $90,622 | $48.33 | -1,875 | 42,011 | 01 Apr 2026 | TPC RP EPA1 LLC |
| Bonnie L. Bassler | RPRX | Class A Ordinary Shares | Award | 1.11% | 815 | 73,947 | 31 Mar 2026 | Direct | ||
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -4.1% | $85,366 | $45.53 | -1,875 | 43,886 | 23 Mar 2026 | TPC RP EPA1 LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -33.3% | $1,498,623 | $45.53 | -32,916 | 65,832 | 23 Mar 2026 | By TPC RP 2021, LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -3.94% | $87,713 | $46.78 | -1,875 | 45,761 | 02 Mar 2026 | TPC RP EPA1 LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -25% | $1,539,821 | $46.78 | -32,916 | 98,748 | 02 Mar 2026 | By TPC RP 2021, LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -3.79% | $84,968 | $45.32 | -1,875 | 47,636 | 23 Feb 2026 | TPC RP EPA1 LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -20% | $1,491,638 | $45.32 | -32,916 | 131,664 | 23 Feb 2026 | By TPC RP 2021, LLC |
| Pablo G. Legorreta | RPRX | Class A Ordinary Shares | Award | 16.8% | 157,828 | 1,098,783 | 11 Feb 2026 | Direct | ||
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Award | 116.4% | 26,626 | 49,511 | 11 Feb 2026 | TPC RP EPA1 LLC | ||
| Christopher Hite | RPRX | Class A Ordinary Shares | Award | 4.04% | 26,626 | 685,136 | 11 Feb 2026 | By SCH Investment Partners LLC | ||
| Marshall Urist | RPRX | Class A Ordinary Shares | Award | 269.9% | 19,970 | 27,368 | 11 Feb 2026 | Direct | ||
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -4.53% | $47,059 | $43.29 | -1,087 | 22,885 | 04 Feb 2026 | TPC RP EPA1 LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -10.4% | $825,853 | $43.29 | -19,076 | 164,580 | 04 Feb 2026 | By TPC RP 2021, LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -20.5% | $265,413 | $42.84 | -6,195 | 23,972 | 03 Feb 2026 | TPC RP EPA1 LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -37.2% | $4,659,584 | $42.84 | -108,759 | 183,656 | 03 Feb 2026 | By TPC RP 2021, LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -16.2% | $245,896 | $42.08 | -5,843 | 30,167 | 02 Feb 2026 | TPC RP EPA1 LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -26% | $4,317,009 | $42.08 | -102,581 | 292,415 | 02 Feb 2026 | By TPC RP 2021, LLC |
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -100% | $821,810 | $41.09 | -20,000 | 0 | 30 Jan 2026 | By Sandy Lamm LLC |
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -50% | $805,110 | $40.26 | -20,000 | 20,000 | 23 Jan 2026 | By Sandy Lamm LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -9.43% | $147,556 | $39.35 | -3,750 | 36,010 | 20 Jan 2026 | TPC RP EPA1 LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -14.3% | $2,590,384 | $39.35 | -65,832 | 394,996 | 20 Jan 2026 | By TPC RP 2021, LLC |
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -33.3% | $790,346 | $39.52 | -20,000 | 40,000 | 16 Jan 2026 | By Sandy Lamm LLC |
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -25% | $815,634 | $40.78 | -20,000 | 60,000 | 09 Jan 2026 | By Sandy Lamm LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -8.62% | $144,059 | $38.42 | -3,750 | 39,760 | 02 Jan 2026 | TPC RP EPA1 LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -12.5% | $2,528,982 | $38.42 | -65,832 | 460,828 | 02 Jan 2026 | By TPC RP 2021, LLC |
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -20% | $769,650 | $38.48 | -20,000 | 80,000 | 02 Jan 2026 | By Sandy Lamm LLC |
| Bonnie L. Bassler | RPRX | Class A Ordinary Shares | Award | 1.34% | 967 | 73,132 | 31 Dec 2025 | Direct | ||
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -16.7% | $786,380 | $39.32 | -20,000 | 100,000 | 26 Dec 2025 | By Sandy Lamm LLC |
* marks a reported price that did not pass the local price check.